CVE-2026-21997 (GCVE-0-2026-21997)

Vulnerability from cvelistv5 – Published: 2026-04-21 20:34 – Updated: 2026-04-22 14:03
VLAI?
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Severity ?
8.5 (High)
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
CWE
  • Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
Assigner
References
Impacted products
Vendor Product Version
Oracle Corporation Oracle Life Sciences Empirica Signal Affected: 9.2.1 , ≤ 9.2.3 (custom)
Create a notification for this product.
Show details on NVD website
To clipboard 

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-21997",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "no"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-04-22T14:02:55.730217Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "cweId": "CWE-284",
                "description": "CWE-284 Improper Access Control",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-04-22T14:03:00.137Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Oracle Life Sciences Empirica Signal",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "lessThanOrEqual": "9.2.3",
              "status": "affected",
              "version": "9.2.1",
              "versionType": "custom"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*",
                  "versionEndIncluding": "9.2.3",
                  "versionStartIncluding": "9.2.1",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).  Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 8.5,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "LOW",
            "integrityImpact": "HIGH",
            "privilegesRequired": "LOW",
            "scope": "CHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-04-21T20:34:58.883Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpuapr2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-21997",
    "datePublished": "2026-04-21T20:34:58.883Z",
    "dateReserved": "2026-01-05T18:07:34.723Z",
    "dateUpdated": "2026-04-22T14:03:00.137Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2",
  "vulnerability-lookup:meta": {
    "epss": {
      "cve": "CVE-2026-21997",
      "date": "2026-04-22",
      "epss": "0.00027",
      "percentile": "0.07763"
    },
    "nvd": "{\"cve\":{\"id\":\"CVE-2026-21997\",\"sourceIdentifier\":\"secalert_us@oracle.com\",\"published\":\"2026-04-21T21:16:24.653\",\"lastModified\":\"2026-04-22T21:24:26.997\",\"vulnStatus\":\"Undergoing Analysis\",\"cveTags\":[],\"descriptions\":[{\"lang\":\"en\",\"value\":\"Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).  Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).\"}],\"metrics\":{\"cvssMetricV31\":[{\"source\":\"secalert_us@oracle.com\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"3.1\",\"vectorString\":\"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N\",\"baseScore\":8.5,\"baseSeverity\":\"HIGH\",\"attackVector\":\"NETWORK\",\"attackComplexity\":\"LOW\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"scope\":\"CHANGED\",\"confidentialityImpact\":\"LOW\",\"integrityImpact\":\"HIGH\",\"availabilityImpact\":\"NONE\"},\"exploitabilityScore\":3.1,\"impactScore\":4.7}]},\"weaknesses\":[{\"source\":\"134c704f-9b21-4f2e-91b3-4a467353bcc0\",\"type\":\"Secondary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-284\"}]}],\"references\":[{\"url\":\"https://www.oracle.com/security-alerts/cpuapr2026.html\",\"source\":\"secalert_us@oracle.com\"}]}}",
    "vulnrichment": {
      "containers": "{\"cna\": {\"metrics\": [{\"cvssV3_1\": {\"scope\": \"CHANGED\", \"version\": \"3.1\", \"baseScore\": 8.5, \"attackVector\": \"NETWORK\", \"baseSeverity\": \"HIGH\", \"vectorString\": \"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N\", \"integrityImpact\": \"HIGH\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"availabilityImpact\": \"NONE\", \"privilegesRequired\": \"LOW\", \"confidentialityImpact\": \"LOW\"}}], \"affected\": [{\"vendor\": \"Oracle Corporation\", \"product\": \"Oracle Life Sciences Empirica Signal\", \"versions\": [{\"status\": \"affected\", \"version\": \"9.2.1\", \"versionType\": \"custom\", \"lessThanOrEqual\": \"9.2.3\"}]}], \"references\": [{\"url\": \"https://www.oracle.com/security-alerts/cpuapr2026.html\", \"name\": \"Oracle Advisory\", \"tags\": [\"vendor-advisory\"]}], \"descriptions\": [{\"lang\": \"en-US\", \"value\": \"Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).  Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).\"}], \"problemTypes\": [{\"descriptions\": [{\"lang\": \"en-US\", \"description\": \"Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal.  While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change).  Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.\"}]}], \"cpeApplicability\": [{\"nodes\": [{\"negate\": false, \"cpeMatch\": [{\"criteria\": \"cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*\", \"vulnerable\": true, \"versionEndIncluding\": \"9.2.3\", \"versionStartIncluding\": \"9.2.1\"}], \"operator\": \"OR\"}]}], \"providerMetadata\": {\"orgId\": \"43595867-4340-4103-b7a2-9a5208d29a85\", \"shortName\": \"oracle\", \"dateUpdated\": \"2026-04-21T20:34:58.883Z\"}}, \"adp\": [{\"title\": \"CISA ADP Vulnrichment\", \"metrics\": [{\"other\": {\"type\": \"ssvc\", \"content\": {\"id\": \"CVE-2026-21997\", \"role\": \"CISA Coordinator\", \"options\": [{\"Exploitation\": \"none\"}, {\"Automatable\": \"no\"}, {\"Technical Impact\": \"partial\"}], \"version\": \"2.0.3\", \"timestamp\": \"2026-04-22T14:02:55.730217Z\"}}}], \"problemTypes\": [{\"descriptions\": [{\"lang\": \"en\", \"type\": \"CWE\", \"cweId\": \"CWE-284\", \"description\": \"CWE-284 Improper Access Control\"}]}], \"providerMetadata\": {\"shortName\": \"CISA-ADP\", \"orgId\": \"134c704f-9b21-4f2e-91b3-4a467353bcc0\", \"dateUpdated\": \"2026-04-22T14:02:51.897Z\"}}]}",
      "cveMetadata": "{\"cveId\": \"CVE-2026-21997\", \"state\": \"PUBLISHED\", \"dateUpdated\": \"2026-04-21T20:34:58.883Z\", \"dateReserved\": \"2026-01-05T18:07:34.723Z\", \"assignerOrgId\": \"43595867-4340-4103-b7a2-9a5208d29a85\", \"datePublished\": \"2026-04-21T20:34:58.883Z\", \"assignerShortName\": \"oracle\"}",
      "dataType": "CVE_RECORD",
      "dataVersion": "5.2"
    }
  }
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or observed by the user.
  • Confirmed: The vulnerability has been validated from an analyst's perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
  • Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
  • Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
  • Not confirmed: The user expressed doubt about the validity of the vulnerability.
  • Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.



Detection rules are retrieved from Rulezet.